General

The following list of published research is intended to serve as a resource for study of inflammatory myopathies.

Sabrina Paganoni and Anthony Amato. Electrodiagnostic Evaluation of Myopathies. Phys Med Rehabil Clin AM. 24 (2013) 193-207. http://dx.doi.org/10.1016/j.pmr.2012.08.017.
William Coley, Sree Rayavarapu and Kanneboyina Nagaraju. Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies. Arthritis Research and Therapy. Coley et al. Arthritis Research & Therapy 2012, 14:209. http://arthritis-research.com/content/14/2/209

Frederick W Miller. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann Rheum Dis 2012; 71(SuppII):i82-i85. doi:10.1136/annrheumdis-2011-200587.
Li Alemo Munters, Ronald F. van Vollenhoven, and Helene Alexanderson. Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis. International Scholarly Research Network. ISRN Rheumatology. Volume 2011, Article ID 463124, 5 pages doi:10.5402/2011/463124.
Helene Alexanderson and Ingrid E. Lundberg. Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Current Opinion.
David J. Gazeley and Mary E. Cronin. Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther Adv Musculoskeletal Disease. 2011 December; 3(6): 315-324
Christine Castro adn Mark Gourley. Diagnosis and treatment of inflammatory myopathy: issues and management. Ther Adv Musculoskeletal Disease. 2012 April; 4(2): 111-120.
Jemima Albayda and Lisa Christopher-Stine. Novel approaches in the treatment of myositis and myopathies. Ther adv musculoskeletal Disease. 2012 October; 4 (5): 369-377.

B. Jane Distad, MD, Anthony A. Amato, MD, Michael D. Weiss, MD. Inflammatory Myopathies. Current Treatment Options in Neurology. 08 January 2011. DOI 10.1007/s11940-010-0111-8.
Geoffrey Connors, MD; Lisa Christopher-Stine, MD; Chester Oddis, MD and Sonye Danoff, MD. Interstitial Lung Disease Associated with the Idiopathic Inflammatory Myopathies. CHEST 2010; 138(6):1464-1474.
I. Loell and I.E. Lundberg. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? 2011 The Association for the Publication of the Journal of Internal Medicine. doi: 10.1111/j.1365-2796.2010.02334.x

Sergio Prieto, Josep M. Grau. The Geoepidemiology of Autoimmune Muscle Disease. Autoimmunity Reviews (2009). doi;10.1016/j.autrev.2009.11.006.
Marions C. Dalakas. Immunotherapy of myositis: issues, concerns and future prospects . Nature Reviews Rheumatology. advanced online publication 2 February 2010; doi:10.1038/nrrheum.2010.2
Marinos C Dalakas. Inflammatory muscle disease: a critical review of pathogenesis and therapies. Current Opinion in Pharmacology (2010), 10:1-7. DOI 10.1016/j.coph.2010.03.001.
Meena Kalluri, MD, Chester V. Oddis, MD. Pulmonary Manifestations of the Idiopathic Inflammatory Myopathies. Clin Chest Med 31 (2010) 501-512. doi:10.1016/j.ccm.2010.05.008.

Pongratz, D. Therapeutic options in autoimmune inflammatory myopathies . J Neurol (2006) 253 [Suppl 5]: V/64–V/65.
I.E. Lunberg & C.J. Forbess. Mortality in Myositis. Clinical and Experimental Rheumatology. 2008; S 109-114.
Ingrid E lundberg & Gustavo A Nader. The Effects of Exercise in Inflammatory Rheumatic Disease. Nature Clinical Practice Rheumatology. 2008; 1-8.

Plotz, Paul and Christopher-Stine, Lisa. Adult inflammatory myopathies . Best Practice & Research Clinical Rheumatology. 2004;18 (3) 331-344,
Dalakas MC. The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: A view to the future from the "bench-to-bedside . J Neurol (2004) 251: 651–657.
Dalakas MC. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials. Neurol Sci (2003) 24:S256–S259.
Mastaglia, F. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am 28 (2002) 723–741.

Mastaglia FL, et al. Immunoglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry 65: 107-110, 1998.

Cronin ME, et al. The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy. J Rheumatol 16: 1225-1228, 1989.